Department of Mental Health and Substance Use, National Institute of Health and Welfare, Helsinki, Finland.
Bipolar Disord. 2010 May;12(3):271-84. doi: 10.1111/j.1399-5618.2010.00810.x.
To test two hypotheses of psychiatric comorbidity in bipolar disorder (BD): (i) comorbid disorders are independent of BD course, or (ii) comorbid disorders associate with mood.
In the Jorvi Bipolar Study (JoBS), 191 secondary-care outpatients and inpatients with DSM-IV bipolar I disorder (BD-I) or bipolar II disorder (BD-II) were evaluated with the Structured Clinical Interview for DSM-IV Disorders, with psychotic screen, plus symptom scales, at intake and at 6 and 18 months. Three evaluations of comorbidity were available for 144 subjects (65 BD-I, 79 BD-II; 76.6% of 188 living patients). Structural equation modeling (SEM) was used to examine correlations between mood symptoms and comorbidity. A latent change model (LCM) was used to examine intraindividual changes across time in depressive and anxiety symptoms. Current mood was modeled in terms of current illness phase, Beck Depression Inventory (BDI), Young Mania Rating Scale, and Hamilton Depression Rating Scale; comorbidity in terms of categorical DSM-IV anxiety disorder diagnosis, Beck Anxiety Inventory (BAI) score, and DSM-IV-based scales of substance use and eating disorders.
In the SEM, depression and anxiety exhibited strong cross-sectional and autoregressive correlation; high levels of depression were associated with high concurrent anxiety, both persisting over time. Substance use disorders covaried with manic symptoms (r = 0.16-0.20, p < 0.05), and eating disorders with depressive symptoms (r = 0.15-0.32, p < 0.05). In the LCM, longitudinal intraindividual improvements in BDI were associated with similar BAI improvement (r = 0.42, p < 0.001).
Depression and anxiety covary strongly cross-sectionally and longitudinally in BD. Substance use disorders are moderately associated with manic symptoms, and eating disorders with depressive mood.
检验双相障碍(BD)精神共病的两个假说:(i)共病与 BD 病程无关,或(ii)共病与心境相关。
在 Jorvi 双相研究(JoBS)中,对 191 名 DSM-IV 双相 I 型障碍(BD-I)或双相 II 型障碍(BD-II)的二级保健门诊和住院患者进行评估,采用 DSM-IV 障碍的结构化临床访谈,伴有精神病筛查,以及症状量表,在入组时和 6 个月和 18 个月时进行评估。对 144 名受试者(65 名 BD-I,79 名 BD-II;188 名存活患者中的 76.6%)进行了三次共病评估。结构方程模型(SEM)用于检验心境症状与共病之间的相关性。使用潜在变化模型(LCM)检验抑郁和焦虑症状在个体内随时间的变化。当前心境用当前疾病阶段、贝克抑郁量表(BDI)、杨氏躁狂量表和汉密尔顿抑郁量表来建模;共病用 DSM-IV 焦虑障碍诊断、贝克焦虑量表(BAI)评分和基于 DSM-IV 的物质使用和饮食障碍量表来建模。
在 SEM 中,抑郁和焦虑表现出很强的横断和自回归相关性;高水平的抑郁与高并发的焦虑相关,且持续时间较长。物质使用障碍与躁狂症状相关(r = 0.16-0.20,p < 0.05),饮食障碍与抑郁症状相关(r = 0.15-0.32,p < 0.05)。在 LCM 中,BDI 的纵向个体内改善与类似的 BAI 改善相关(r = 0.42,p < 0.001)。
BD 中抑郁和焦虑在横断和纵向都有很强的相关性。物质使用障碍与躁狂症状中度相关,饮食障碍与抑郁情绪相关。